TrialAdvances in therapy2025

Real-World Safety and Effectiveness of Dimethyl Fumarate in Patients with MS: Results from the ESTEEM Phase 4 and PROCLAIM Phase 3 Studies with a Focus on Older Patients.

Yang Mao-Draayer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.